Immunovant shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $958k | 34k | 28.51 |
| 2024-06-30 | $887k | 34k | 26.40 |
| 2023-12-31 | $1.2M | 29k | 42.13 |
| 2023-09-30 | $1.1M | 29k | 38.39 |
| 2023-06-30 | $540k | 29k | 18.97 |
| 2023-03-31 | $347k | 22k | 15.51 |
| 2022-12-31 | $384k | 22k | 17.75 |
| 2022-09-30 | $121k | 22k | 5.58 |
| 2022-03-31 | $139k | 25k | 5.51 |
| 2021-12-31 | $41k | 4.8k | 8.52 |
| 2021-09-30 | $130k | 15k | 8.69 |
| 2021-06-30 | $45k | 4.2k | 10.57 |
| 2021-03-31 | $241k | 15k | 16.04 |
| 2020-12-31 | $693k | 15k | 46.18 |
| 2020-09-30 | $528k | 15k | 35.19 |
| 2020-06-30 | $230k | 9.4k | 24.35 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors